Drug class
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Converting Enzyme (ACE) Inhibitors are an established pharmacologic class of cardiovascular agents that lower blood pressure and reduce cardiac workload. Read more about Angiotensin Converting Enzyme (ACE) Inhibitors
191 drugs in this class 69 manufacturers
Drugs in Angiotensin Converting Enzyme (ACE) Inhibitors
ENALAPRIL MALEATE
LISINOPRIL
ENALAPRIL-HYDROCHLOROTHIAZIDE (enalapril maleate/hydrochlorothiazide)
AMLODIPINE BESYLATE-BENAZEPRIL (amlodipine besylate/benazepril HCl)
ENALAPRIL MALEATE
QUINAPRIL HCL
LOTENSIN (benazepril HCl)
ENALAPRIL MALEATE
Angiotensin Converting Enzyme (ACE) Inhibitors are an established pharmacologic class of cardiovascular agents that lower blood pressure and reduce cardiac workload.
They function by competitively blocking the angiotensin-converting enzyme, which prevents the conversion of angiotensin I to the potent vasoconstrictor angiotensin II and decreases aldosterone secretion, thereby promoting systemic vasodilation and natriuresis.
Clinically, medications in this class are widely indicated for the management of essential hypertension, heart failure with reduced ejection fraction, and acute myocardial infarction.
They are also utilized to provide renal protection and slow the progression of chronic kidney disease, particularly diabetic nephropathy.
-
fda.gov
Angiotensin Converting Enzyme (ACE) Inhibitors are an established pharmacologic class of cardiovascular agents that lower blood pressure and reduce cardiac workload
-
nih.gov
Angiotensin Converting Enzyme (ACE) Inhibitors are an established pharmacologic class of cardiovascular agents that lower blood pressure and reduce cardiac workload They function by competitively blocking the angiotensin-converting enzyme, which prevents the conversion of angiotensin I to the potent vasoconstrictor angiotensin II and decreases aldosterone secretion, thereby promoting systemic vasodilation and natriuresis Clinically, medications in this class are widely indicated for the manageme...
-
nih.gov
They function by competitively blocking the angiotensin-converting enzyme, which prevents the conversion of angiotensin I to the potent vasoconstrictor angiotensin II and decreases aldosterone secretion, thereby promoting systemic vasodilation and natriuresis They are also utilized to provide renal protection and slow the progression of chronic kidney disease, particularly diabetic nephropathy
-
fda.gov
Clinically, medications in this class are widely indicated for the management of essential hypertension, heart failure with reduced ejection fraction, and acute myocardial infarction
-
fda.gov
Clinically, medications in this class are widely indicated for the management of essential hypertension, heart failure with reduced ejection fraction, and acute myocardial infarction
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.